Sonova Holding AG (SONVY)
57.13
+1.09
(+1.94%)
USD |
OTCM |
May 02, 16:00
Sonova Market Cap: 17.03B for May 2, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 02, 2024 | 17.03B |
| May 01, 2024 | 16.71B |
| April 30, 2024 | 16.52B |
| April 29, 2024 | 16.93B |
| April 26, 2024 | 16.80B |
| April 25, 2024 | 16.48B |
| April 24, 2024 | 16.67B |
| April 23, 2024 | 16.65B |
| April 22, 2024 | 16.62B |
| April 19, 2024 | 16.18B |
| April 18, 2024 | 16.17B |
| April 17, 2024 | 16.28B |
| April 16, 2024 | 16.53B |
| April 15, 2024 | 16.65B |
| April 12, 2024 | 16.64B |
| April 11, 2024 | 17.01B |
| April 10, 2024 | 16.68B |
| April 09, 2024 | 17.01B |
| April 08, 2024 | 16.88B |
| April 05, 2024 | 16.68B |
| April 04, 2024 | 16.66B |
| April 03, 2024 | 16.85B |
| April 02, 2024 | 16.68B |
| April 01, 2024 | 17.15B |
| March 28, 2024 | 17.28B |
| Date | Value |
|---|---|
| March 27, 2024 | 17.40B |
| March 26, 2024 | 16.95B |
| March 25, 2024 | 16.98B |
| March 22, 2024 | 17.41B |
| March 21, 2024 | 18.25B |
| March 20, 2024 | 18.14B |
| March 19, 2024 | 18.11B |
| March 18, 2024 | 17.95B |
| March 15, 2024 | 18.29B |
| March 14, 2024 | 19.47B |
| March 13, 2024 | 19.33B |
| March 12, 2024 | 19.27B |
| March 11, 2024 | 18.98B |
| March 08, 2024 | 19.38B |
| March 07, 2024 | 19.11B |
| March 06, 2024 | 18.72B |
| March 05, 2024 | 18.55B |
| March 04, 2024 | 18.64B |
| March 01, 2024 | 18.66B |
| February 29, 2024 | 18.38B |
| February 28, 2024 | 18.46B |
| February 27, 2024 | 19.10B |
| February 26, 2024 | 19.46B |
| February 23, 2024 | 19.64B |
| February 22, 2024 | 19.62B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
9.424B
Minimum
Mar 23 2020
27.30B
Maximum
Nov 04 2021
17.37B
Average
16.03B
Median
Feb 08 2023
Market Cap Benchmarks
| AC Immune SA | 239.34M |
| CRISPR Therapeutics AG | 4.677B |
| Addex Therapeutics Ltd | 9.459M |
| NLS Pharmaceutics Ltd | 5.892M |
| Molecular Partners AG | 123.70M |
Market Cap Related Metrics
| PS Ratio | 4.242 |
| Price to Book Value | 7.384 |
| Price to Free Cash Flow | 26.17 |
| Price | 57.13 |
| Earnings Yield | 3.87% |
| Operating PE Ratio | 22.50 |
| Normalized PE Ratio | 25.86 |